SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $376,988 | -72.4% | 128,665 | -46.8% | 0.00% | -100.0% |
| Q1 2024 | $1,365,283 | +621.0% | 241,643 | +493.4% | 0.00% | – |
| Q2 2023 | $189,362 | -73.6% | 40,723 | -73.8% | 0.00% | -100.0% |
| Q1 2023 | $717,019 | -67.8% | 155,199 | -43.7% | 0.00% | -50.0% |
| Q4 2022 | $2,226,775 | +27.4% | 275,591 | -12.5% | 0.00% | 0.0% |
| Q3 2022 | $1,748,000 | +29.4% | 315,014 | +21.4% | 0.00% | 0.0% |
| Q2 2022 | $1,351,000 | +196.3% | 259,397 | +745.9% | 0.00% | – |
| Q4 2021 | $456,000 | -35.4% | 30,664 | -18.0% | 0.00% | -100.0% |
| Q3 2021 | $706,000 | +31.0% | 37,387 | +29.0% | 0.00% | – |
| Q2 2021 | $539,000 | -44.4% | 28,977 | -32.0% | 0.00% | -100.0% |
| Q1 2021 | $970,000 | -54.7% | 42,606 | -56.8% | 0.00% | -50.0% |
| Q4 2020 | $2,141,000 | – | 98,631 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $41,527,000 | 15.56% |
| Samsara BioCapital, LLC | 1,675,579 | $38,136,000 | 7.03% |
| First Light Asset Management, LLC | 2,058,447 | $46,850,000 | 3.11% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $22,792,000 | 1.83% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,983,000 | 1.50% |
| Altium Capital Management LP | 226,719 | $5,160,000 | 1.43% |
| Opaleye Management Inc. | 341,950 | $7,783,000 | 1.14% |
| Parkman Healthcare Partners LLC | 202,696 | $4,613,000 | 1.07% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $3,171,000 | 0.84% |
| Eventide Asset Management | 2,370,975 | $53,963,000 | 0.80% |